GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » 5-Year Yield-on-Cost %

Advanced Oncotherapy (FRA:R3I1) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Advanced Oncotherapy 5-Year Yield-on-Cost %?

Advanced Oncotherapy's yield on cost for the quarter that ended in Jun. 2022 was 0.00.


The historical rank and industry rank for Advanced Oncotherapy's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:R3I1's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.15
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Advanced Oncotherapy's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Advanced Oncotherapy's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Oncotherapy's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Oncotherapy's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Advanced Oncotherapy's 5-Year Yield-on-Cost % falls into.



Advanced Oncotherapy 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Advanced Oncotherapy is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Advanced Oncotherapy  (FRA:R3I1) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Advanced Oncotherapy 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Oncotherapy (FRA:R3I1) Business Description

Traded in Other Exchanges
N/A
Address
4 Tenterden Street, Third Floor, London, GBR, W1S 1TE
Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.

Advanced Oncotherapy (FRA:R3I1) Headlines

No Headlines